Clinical Data Management White Paper & Articles

  1. Choosing RTSM? Evaluate The Team Running It, Not Just The Software 2/25/2026

    High-performing RTSM requires more than just code. Discover why team continuity and clinical expertise are the most overlooked factors in reducing trial risk and ensuring regulatory compliance.

  2. Why The TrialKit Platform License Agreement Changes The Economics Of Clinical Trials 2/24/2026

    A platform‑based pricing model removes change‑order friction, enabling predictable budgets and faster study adjustments. It supports operational agility and portfolio‑level efficiency as trials evolve.

  3. Evaluating Wearable Data Platforms For Endpoint-Driven Studies 2/24/2026

    Endpoint‑driven studies need platforms that unify wearable data with trial systems, support derived measures, and ensure traceability so continuous data becomes reliable clinical evidence.

  4. When To Use Wearables In A Clinical Trial And How to Get Started 2/24/2026

    Wearables work best when they close real measurement gaps — from irregular symptoms to mobility and sleep. In a unified data environment, they deliver richer insights without added complexity.

  5. How AI Activates The Full Potential Of Wearables In Clinical Research 2/24/2026

    Wearables provide continuous real‑world insights, and AI turns raw sensor data into meaningful evidence. With unified data infrastructure, studies gain more reliable, patient‑centered endpoints.

  6. 5 Projections For 2026: Navigating The New Normal In Clinical Trials 2/18/2026

    In 2026, clinical trial success depends on moving from AI hype to proven utility. Unified data and seamless site experiences are no longer optional; they are the keys to trial resilience.

  7. How Platform Unification Is Shaping Clinical Trial Technology 2/18/2026

    As we look toward 2026, the conversation around clinical trial technology is shifting from simple digitization to true platform unification.

  8. Rethinking Technology For Patients And Sites In Clinical Trials 2/18/2026

    The solution to administrative burden in clinical trials is not in adding more tools, but in improved integration that allows software to fade into the background.

  9. State Of Clinical Trial Technology: The AI Inflection Point 2/12/2026

    Digital maturity gaps are widening in clinical research. Connected workflows speed insights and execution, while manual processes leave organizations increasingly behind.

  10. Digital Protocols Are At An Inflection Point: A Conversation With Novartis And TransCelerate Leaders 1/23/2026

    Digital protocols could reduce manual effort and enable rapid and more consistent downstream study execution, reporting, and submission processes. TransCelereate BioPharma's Rob DiCicco and Novartis' Bill Illis explain.